References
- George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warner I. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the american society of hematology. Blood 1996;88:3–40.
- British Committee for Standards in Hematology General Hematology Task Force Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Hematol 2003;120: 574–596.
- Scaradavou A. Splenectomy-sparing, long-term maintenance with anti-D for chronic immune (idiopathic) thrombocyto-penic purpura: The New York hospital experience. Semin Hematol 2000;37 (Suppl 1):42–44.
- Newman GC, Novoa MV, Fodero EM, Lesser ML, Woloski BM, Bussel JB. A dose of 75 microg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg/kg/d in adults with immune thrombocytopenic purpura. Br J Hematol 2001;112: 1076–1078.
- George JN, Raskob GE, Vesely SK, Moore D, Jr, Lyons RM, Cobos E, Towell BL, Klug P, Guthrie TH. Initial management of immune thrombocytopenic purpura in adults: A random-ized controlled trial comparing intermittent anti-D with routine care. Am J Hematol 2003;74:161–169.
- Bussel JB, Graziano JN, Kimberly RP, Pahwa S, Aledort LM. Intravenous anti-D treatment of immune thrombocytopenic purpura: Analysis of efficacy, toxicity, and mechanism of effect. Blood 1991;77:1884–1893.
- Cines DB, McKenzie SE, Siegel DL. Mechanisms of action of therapeutics in idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2003;25 (Suppl 1):552–556.
- Stucki M, Moudry R, Kempf C, Omar A, Schlegel A, Lerch PG. Characterisation of a chromatographically produced anti-4132#D immunglobulin product. J Chromatogr B 1997;700: 241–248.
- MacKenzie IZ, Bichler J, Mason GC, Lunan CB, Stewart P, Al-Azzawi F, De Bono M, Watson N, Andresen I. Efficacy and safety of a new, chromatographically purified rhesus (D) immunoglobulin. Eur J Obstet Gynecol Reprod Biol 2004; 117:154–161.
- Adams JR, Nathan DP, Bennett CL. Pharmacoeconomics of therapy for ITP: Steroids, iv. Ig, anti-D, and splenectomy. Blood Rev 2002;16:65–67.
- Chong BH, Ho SJ. Autoimmune thrombocytopenia. J Thromb Haemost 2005;3:1763–1772.
- Salama A, Kiefel V, Amberg R, Mueller-Eckhardt C. Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rho(D)). Blut 1984;49:29–35.
- Salama A, Kiefel V, Mueller-Eckhardt C. Effect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombo-cytopenia. Am J Hematol 1986;22:241–250.
- Boughton BJ, Chakraverty R, Baglin TP, Simpson A, Galvin G, Rose P, Rohlova B. The treatment of chronic idiopathic thrombocytopenia with anti-D (Rho) immunoglobulin: Its effectiveness, safety and mechanism of action. Clin Lab Haematol 1988;10:275–284.
- Rodeghiero F, Schiavotto C, Castarnan G, Vespignani M, Ruggeri M, Dini E. A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins. Haematolo-gica 1992;77:248–252.
- Ramadan KM, El-Agnaf M. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura. Chin Lab Haematol 2005;27: 267–269.
- Scaradavou A, Woo B, Woloski BMR, Cunningham-Rundles S, Ettinger LJ, Aledort LM, Bussel JB. Intravenous anti-D treatment of immune thrombocytopenic purpura: Experience in 272 patients. Blood 1997;89: 2689–2700.
- Cooper N, Woloski BM, Fodero EM, Novoa M, Leber M, Beer JH, Bussel JB. Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy? Blood 2002;99:1922–1927 .
- George JN, Woolf SH, Raskob GE. Idiopathic thrombocyto-penic purpura: A guideline for diagnosis and management of children and adults. American Society of Hematology. Ann Med 1998;30:38–44.
- Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002;346:995–1008.
- Gaines AR. Acute onset hemoglobinemia and/or hemoglobi-nuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients. Blood 2000;95:2523–2529.
- Gaines AR. Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh (o) (D) immune globulin intravenous administration for immune thrombocytopenic purpura. Blood 2005;106: 1532–1537.